Premium
Erratum to Puricelli et al., “Heregulin inhibits proliferation via ERKs and phosphatidyl inositol 3‐kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells”. Int J Cancer 2002;100:642‐53
Publication year - 2005
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.21414
Subject(s) - neuregulin , inositol , activator (genetics) , cancer research , kinase , plasminogen activator , chemistry , signal transduction , biology , microbiology and biotechnology , endocrinology , medicine , receptor
The original article to which this Erratum refers was published in International Journal of Cancer (2002) 100(6) 642–653 DOI: 10.1002/ijc.10533